An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Aug. 30 unanimously recommended the Pfizer Inc. and BioNTech SE Covid-19 vaccine for people age 16 and older, an important step that could help accelerate vaccine mandates in the United States.
Participants in Novavax Inc.’s late-stage Covid-19 vaccine trial can be considered fully vaccinated two weeks after completing their two-dose vaccine regimen, the U.S. Centers for Disease Control and Prevention said on Aug. 30.
The number of coronavirus patients in U.S. hospitals breached 100,000, the highest level in eight months, according to the Department of Health and Human Services, as a resurgence of Covid-19 spurred by the highly contagious Delta variant strains the nation’s health care system.
Half of children aged 12 to 17 have received at least their first vaccination dose against Covid-19, and that age group has the fastest growth rate in vaccinations, the White House said on Aug. 27.
New York Governor Kathy Hochul revealed 12,000 more people died of Covid-19 than was reported under her predecessor, making good on Hochul’s promise for greater transparency on just her second day leading the state.
Pfizer Inc. on Aug. 25 said a booster dose of the company’s two-shot Covid-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the drugmaker seeks U.S. regulatory approval for a third injection.
U.S. health regulators could approve a third Covid-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced eight-month gap, the Wall Street Journal reported on Aug. 25.
More studies into vaccinated populations show that although antibody responses drop months after vaccination against Covid-19, they still dramatically protect against severe disease and hospitalization. Studies are also continuing on the value and efficacy of booster shots, particularly against the Delta variant.
A booster dose of Johnson & Johnson’s Covid-19 vaccine sharply increased levels of antibodies against the coronavirus, according to interim data from two small, early-stage trials, the company said in a press release on Aug. 25.
The Centers for Disease Control and Prevention (CDC) released a report showing that unvaccinated people are 29 times more likely to be hospitalized with Covid-19 than those who are fully vaccinated against the disease.